trending Market Intelligence /marketintelligence/en/news-insights/trending/2p5GBqYZEENdc5yUmOxbxg2 content esgSubNav
In This List

FibroGen plans follow-on offering of common stock

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


FibroGen plans follow-on offering of common stock

FibroGen Inc. plans to offer and sell up to $300 million of its common stock in an underwritten follow-on offering.

The company expects to grant the underwriters an option to buy additional common shares.

Net proceeds will be used to fund the expansion of product development, manufacturing and commercialization activities as well as for general corporate purposes.

Goldman Sachs & Co. LLC, Citigroup and Leerink Partners LLC are acting as joint book-running managers for the offering.